Postpartum Incontinence Care Lacking, Survey Reveals
A recent Aeroflow Urology survey of 966 mothers reveals a significant gap in postpartum incontinence care. Despite 85% of...
Jon Napitupulu
Study Shows ux111 Gene Therapy Improves Clinical Function in Children with Sanfilippo Syndrome Type A
Ultragenyx Pharmaceutical announced positive data from its pivotal and long-term follow-up studies of UX111 (ABO-102), a gene therapy for...
Annovis’ Buntanetap Enters Phase 3 Alzheimer’s Study
Annovis Bio has initiated its pivotal Phase 3 trial for buntanetap, an oral drug candidate for early-stage Alzheimer’s diseaseAlzheimer’s...
Unbuzzd™ Clinical Trial Success Announced by Quantum Biopharma
Quantum BioPharma Ltd. announced positive results from a clinical trial of its dietary supplement, unbuzzd™, demonstrating its efficacy in...
GlucoTrack Announces Successful Human Clinical Trial of CGM
Glucotrack, Inc. has successfully completed its first human clinical study of a continuous blood glucose monitor (CBGM) implanted in...
10 Bold Solutions to End Cancer: City of Hope’s Plan
City of Hope, a leading cancer research and treatment organization, has outlined strategies to combat rising cancer rates, particularly...
FDA Approves Susvimo for Diabetic Blindness
The FDA approved Susvimo (ranibizumab injection) for diabetic macular edema (DME), a leading cause of vision loss. This marks...
Auron Therapeutics Announces FDA Clearance and Series B Financing
Auron Therapeutics, a clinical-stage biotech company, announced progress on its lead KAT2A/B program and candidate AUTX-703, along with a...
FLT201 Gene Therapy Shows Promise in Gaucher Disease Trial
Spur Therapeutics released positive Phase 1/2 trial data for FLT201, a gene therapy for Gaucher disease type 1. The...
SiteOne Announces Positive Phase 1 Data for Novel Non-Opioid Pain Drug
SiteOne Therapeutics announced positive Phase 1 clinical trial results for STC-004, its lead NaV1.8 inhibitor for non-opioid pain treatment....